Want to join the conversation?
Construction and mining equipment manufacturer $CAT 3Q15 earnings fell 64% to $0.62 per share from a year ago period. Revenue fell 19% to $11Bil, hurt by falls in both Machinery, Energy & Transportation segment sales and Financial Products segment revenues.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.